Kiromic BioPharma Inc

NASDAQ:KRBP   3:59:51 PM EDT
2.00
+0.01 (+0.50%)
Products

Kiromic Biopharma Announced On Dec 16 Submission Of Two Investigational New Drug Applications With U.S. FDA

Published: 12/17/2020 16:36 GMT
Kiromic BioPharma Inc (KRBP) - Kiromic Biopharma - Announced on Dec 16 Submission of Two Investigational New Drug Applications With U.S. FDA.
Kiromic Biopharma- Ind Application for Initiation of Phase 1 Clinical Trial of Iv Administered Allogenic Car-t for Eoc, Malignant Pleural Mesothelioma.
Kiromic Biopharma - Ind Application for Initiation of Phase 1 Clinical Trial of Ip Administered Allogenic Car-t for Eoc and Mpm.